All Pharma News
Barinthus Bio`s HPV immunotherapy underwhelms in early study

Barinthus Bio`s HPV immunotherapy underwhelms in early study
PRESS RELEASE
20 Apr 2024
Share Share
Barinthus Bio Reports Topline Phase 1b/2 VTP-200 HPV Infection Data

Barinthus Bio Reports Topline Phase 1b/2 VTP-200 HPV Infection Data
GLOBENEWSWIRE
18 Apr 2024
Share Share
Barinthus Bio Reports Full Year 2023 Financial Results and Update on

Barinthus Bio Reports Full Year 2023 Financial Results and Update on
GLOBENEWSWIRE
20 Mar 2024
Share Share
Barinthus Bio Provides a Financial Update

Barinthus Bio Provides a Financial Update
GLOBENEWSWIRE
05 Jan 2024
Share Share
New partnership aims to advance vaccine against MERS coronavirus

New partnership aims to advance vaccine against MERS coronavirus
GLOBENEWSWIRE
21 Dec 2023
Share Share
Barinthus` gets $35M booster from CEPI to develop MERS shot

Barinthus` gets $35M booster from CEPI to develop MERS shot
Annalee Armstrong FIERCE BIOTECH
21 Dec 2023
Share Share
Vaccitech reemerges as Barinthus with hep B data

Vaccitech reemerges as Barinthus with hep B data
Annalee Armstrong FIERCE BIOTECH
10 Nov 2023
Share Share
Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution

Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution
GLOBENEWSWIRE
06 Nov 2023
Share Share
Vaccitech Reports Second Quarter 2023 Financial Results

Vaccitech Reports Second Quarter 2023 Financial Results
GLOBENEWSWIRE
10 Aug 2023
Share Share
Vaccitech Doses First Patient in PCA001, Phase 1/2 Clinical Trial of VTP-850

Vaccitech Doses First Patient in PCA001, Phase 1/2 Clinical Trial of VTP-850
GLOBENEWSWIRE
12 Jun 2023
Share Share